Back

India has built several AI tools but quite recognised ones are Sarvam AI and Krutrim, now we all know the standards of Krutrim! India is again winning in consumption but not in manufacturing, startups can get a lot of users from India to test or to

It's just me or the medial app is quite (not Active) abit as compared to months ago.

I feel like this platform still lacks luster when compared to any other platforms out there in terms of content, but I like the UI and for that I will stick around, and I really hope it grows.

Do you guys find any gap in women's western wear apparels. as there is no good indian brand as compared to HnM nd zara. where exactly are we lacking and what can be implemented to be one of top Indian brand for western wear. just Like shein came and

i have recently started a small jewellery business online using instagram for now but unable to attract people to buy it, even when the pricing is quite low as compared to blinkit, zepto, etc. can anyone suggest what can be done here ?

medial needs feeds instead of latest in homepage. because it is restricting the content for avid users as when we refresh, the posts we have already seen still comes on top. we need more randomisation here.

Does india really need wealth management firms? The no of ultra high income Indians is quite low as compared to countries like USA so what do you people think is the JV really needed? What's your opinions!

Just as a caution for a lot of you. When opening a digital Demat account on any investing platform be very careful. Given the poor cyber security environment, the risk of your Kyc being leaked or sold is very much there. Just pathetic and irrespons

Unpopular opinion but I think we should NOT build our business like: 1. Idea 2. Product 3. Audience Instead we should pursue 1. Idea 2. Audience 3. Product Building a product is often quite easy compared to building an audience.

India exports pharmaceuticals to over 200 countries. It supplies more than half of Africa's generic medicine needs, almost 40% of the US's generic demand, and about 25% of the UK's medicine.